tenofovir disoproxil succinate - medicine shortage information

Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Sort by: Updated date | Shortage status | Trade name

Product details	Supply Impact Dates	Further Details
TENOFOVIR / EMTRICITABINE SANDOZ 301/200 tenofovir disoproxil succinate / emtricitabine 301 mg/200 mg film-coated tablet bottle AUST R: 326237 Active ingredients: emtricitabine tenofovir disoproxil succinate Dosage form: Tablet, film coated Sponsor: Sandoz Pty Ltd Phone: 1800 726 369	From 03 Nov 2023 to 03 Mar 2025	Shortage status: Current Availability: Unavailable Reason: Manufacturing Management action: The sponsor is working to expedite the next shipment. An unregistered product has been approved for supply under Section 19A. The approval holder Phero Pharma Pty Ltd can be contacted on 1800 720 020 for enquiries about supply.

Product details

Supply Impact Dates

Further Details

TENOFOVIR / EMTRICITABINE SANDOZ 301/200 tenofovir disoproxil succinate / emtricitabine 301 mg/200 mg film-coated tablet bottle
AUST R: 326237
Active ingredients:
emtricitabine
tenofovir disoproxil succinate

Dosage form:
Tablet, film coated

Sponsor:
Sandoz Pty Ltd

Phone:
1800 726 369

From
03 Nov 2023
to
03 Mar 2025

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
The sponsor is working to expedite the next shipment. An unregistered product has been approved for supply under Section 19A. The approval holder Phero Pharma Pty Ltd can be contacted on 1800 720 020 for enquiries about supply.